COVID-19 hospitalized patients frequently have underlying AF, which confers a higher risk of adverse hospital outcomes and mortality, even after adjusting for baseline comorbidities. Heightened awareness is needed in the treatment of hospitalized COVID-19 patients with AF.
Keyphrases
- coronavirus disease
- atrial fibrillation
- sars cov
- end stage renal disease
- risk factors
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- heart failure
- oral anticoagulants
- respiratory syndrome coronavirus
- prognostic factors
- peritoneal dialysis
- left atrial appendage
- cardiovascular events
- catheter ablation
- direct oral anticoagulants
- cardiovascular disease
- percutaneous coronary intervention
- type diabetes
- metabolic syndrome
- adipose tissue
- combination therapy
- patient reported